← Back to The Retatrutide Report Research Overview Retatrutide is a synthetic triple agonist peptide that targets three receptors simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). These receptors belong to the class B G protein-coupled receptor family, sitting on cell surfaces and relaying signals inward […]

← Back to The Retatrutide Report Retatrutide (LY3437943) is a synthetic peptide compound designed to co-activate three distinct G protein-coupled receptors simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). That triple agonist profile makes it structurally and pharmacologically distinct from earlier incretin-based compounds, and it raises […]

← Back to The Retatrutide Report GIPR-Mediated Adipocyte Signaling: What Current Research Reveals About Retatrutide’s Mechanism at the GIP Receptor Section 1: Research Context Retatrutide is a synthetic triple receptor agonist designed to engage three distinct G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucagon receptor (GCGR), and the glucose-dependent insulinotropic polypeptide receptor (GIPR). […]

← Back to The Retatrutide Report Research Overview Retatrutide (LY3437943) represents a structurally distinct pharmacological probe within the incretin receptor agonist class, notable for its simultaneous engagement of three class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). Unlike dual agonists that target […]

An examination of Phase 3 trial findings from the TRIUMPH-4 and TRANSCEND-T2D-1 studies, covering retatrutide’s triple-receptor mechanism and what the late-stage data does and does not confirm.

Retatrutide GCGR Signaling and Hepatic Lipid Metabolism: Research Mechanisms and Study Limitations

← Back to The Retatrutide Report Research Overview Retatrutide, also designated LY3437943, is a synthetic peptide compound designed to engage three receptor targets simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). Each receptor has a distinct pharmacological profile, and the GCGR component has drawn serious attention […]